Showing results (201-210 of 274) with videos related to
Sort By:
Pageof 28
Haematologica|April 24, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myelomaWenqiang Yan, Chen Qiu, Jieqiong Zhou, et al.Cancer Biology & Medicine|March 12, 2025
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphomaYi Wang, Yuting Yan, Dandan Shan, et al.Haematologica|May 30, 2024
LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myelomaLixin Gong, Hao Sun, Lanting Liu, et al.Hematology (Amsterdam, Netherlands)|October 7, 2024
When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional studyXincheng Jiang, Xiaoyan Han, Fengyan Jin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.Scientific Reports|November 26, 2020
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironmentLanting Liu, Zhen Yu, Hui Cheng, et al.Cancers|January 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United StatesJingyu Xu, Meng Shu, Hsingwen Chung, et al.Cytometry. Part B, Clinical Cytometry|September 8, 2025
Hematopathological profile of plasmacytoid dendritic cell proliferation associated with non-myeloid acute leukemiaXiaojin Cai, Yanyan Song, Weichao Fu, et al.Chinese Medical Journal|January 17, 2017
Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic LeukemiaHeng Li, Shu-Hua Yi, Wen-Jie Xiong, et al.Eye and Vision (London, England)|January 6, 2025
Whole-genome sequencing identifies novel loci for keratoconus and facilitates risk stratification in a Han Chinese populationYinghao Yao, Xingyong Li, Lan Wu, et al.Pageof 28